Lifesciences
Many financial firms still use outdated systems which lack the capabilities to manage large amounts of data with flexibility while abiding by strict security regulations.
Register for this webinar to see how we helped a leading mortgage provider modernise their processes with the CARA Platform, with controlled access, efficient workflow and ease of use. fme designed and oversaw the migration process for a smooth and easy process to better data and content management.
Webinar objectives:
- Find out how fme design a migration process to manage large data volumes and fit within desired timelines
- See how the CARA Platform can consolidate multiple docbases giving companies control and security
- Learn how you can improve user experience while cutting costs
About Generis
Generis help Life Science companies to decrease their time to market by providing a comprehensive platform for the core processes, data, and content of the product development lifecycle.
60% of the top 20 life sciences companies rely on unified CARA Life Sciences Platform™ providing standardised apps for Regulatory, Quality, Safety, and Clinical processes powered by a single information lake that gives users instant access to cross-functional data and enables powerful process optimisation; including AbbVie, AstraZeneca, Biogen, Gilead, Bayer, Pfizer, and Merck KGaA.
About fme
me US, LLC was founded in 2010 as a subsidiary of fme AG. fme US focuses on Enterprise Content Management Solutions for clients in the Life Sciences Industry in the United States and Canada and is based in Danbury, CT. fme is partnered with the leading content management platform vendors including OpenText, Microsoft, Box and Generis.
